Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005
Authors: Bookman, Michael A | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | October 3, 2024 | PubMed abstract
